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Prostate cancer incidence rates have increased due to prostate 
specific antigen (PSA) testing and subsequent prostate biopsy.  
The majority of prostate biopsies are transrectal (Figure 1), 
involve that taking of between 6 and 12 tissue samples (cores) 
and last for approximately 15-30 minutes.  
Our aim was to investigate mens’ experience of prostate biopsy, 
and the effect of this on their quality of life (QoL) in the weeks 
post-biopsy. 
Men (n=811 who were 4-6 weeks post-biopsy were given a 
questionnaire in 4 clinics in the Republic of Ireland (RoI)  and 2 
in northern Ireland (NI).  Mens’ biopsy experience was 
investigated by asking men to score eighteen survey-specific 
statements on a four-point Likert scale.  QoL was measured using 
the EQ-5D-5L. Association between biopsy experience and QoL 
was investigated by multivariate ordinal logistic regression. 
Introduction Methods 
This large, population-based study, will present novel data on the long-term psychological wellbeing of PCa survivors.   
 
Figure 2. Frequency with which men agree/strongly agree with statements about their prostate biopsy 
experience, grouped by biopsy result (*Significant difference between groups (p<0.05)) 
Overall, 41% of men returned a completed questionnaire (RoI: 49% 273/561, NI: 25% 62/250). 
35% were diagnosed with prostate cancer, 33% were not and 32% had either not received, or had 
an equivocal result at questionnaire completion.   
 
Most respondents reported that the biopsy was necessary (90%), they were ‘glad’ they had it 
done (90%), and it made them feel ‘reassured’ (83%; Figure 2).  However, men also described it 
as uncomfortable (76%), unpleasant (66%), anxiety causing (59%) and painful (53%).  Men who 
had a benign biopsy result were more likely to describe the experience in negative terms, 
compared to men who were diagnosed with cancer (Figure 2).   
Results 
Most men described the biopsy in positive terms.  
However, poor experiences were associated with low 
QoL, after adjusting for cancer diagnosis and post-
biopsy symptoms experienced.   
Increased awareness of the effect of prostate biopsy 
on men among clinical teams may improve their 
experience and QoL post-biopsy. 
Conclusions 
Figure 1. The prostate biopsy procedure 
    HRQoL 
Characteristics   Univariate OR 
(95%CI) 
  Multivariate OR 
(95%CI) 
  
Biopsy result No cancer 1   1   
  Cancer 2.24 (1.34,3.75) P<0.01 1.97 (1.12,3.46) P=0.02 
  Unknown/equivocal 1.65 (0.95,2.86) P=0.07 1.30 (0.74,2.29) P=0.37 
Biopsy experience  
Reassured agree/strongly agree 0.33 (0.15,0.69) P<0.01 0.30 (0.14,0.68)* P<0.01 
Embarrassing agree/strongly agree 1.65 (1.05,2.60) P=0.03 1.68 (1.02,2.76)* P=0.04 
Painful agree/strongly agree 1.39 (0.88,2.18) P=0.16 1.66 (1.03,2.67)* P=0.04 
Stressful agree/strongly agree 1.74 (1.11,2.70) P=0.01 1.77 (1.10,2.85)* P=0.02 
Scared agree/strongly agree 1.81 (1.12,2.92) P=0.02 1.74 (0.96,3.16)* P=0.07 
Exhausting agree/strongly agree 1.71 (1,032.85) P=0.04 1.71 (0.97,3.01)* P=0.06 
Worried agree/strongly agree 1.88 (1,20,2.94) P=0.01 1.80 (1.05,3.10)* P=0.03 
Uncomfortable agree/strongly agree 1.75 (0.98,3.12) P=0.06 1.72 (0.94,3.16)* P=0.08 
*Adjusted for age at biopsy, marital status, jurisdiction, health anxiety, comorbidity at biopsy, urinary/sexual symptoms pre-biopsy, side effects 
post-biopsy, and biopsy result.  Disagree/strongly disagree was the reference group for each of the biopsy experience statements 
Table 1. Ordinal logistic regression analysis of factors associated with low QoL among men 
who underwent prostate biopsy 
Reassured Anxious Stressful Scared
Peace of
mind
Unpleasant
Uncomfortab
le
Worried Glad Painful
Cancer 80% 52% 41% 22% 75% 63% 74% 36% 92% 49%
No Cancer 78% 65% 51% 29% 80% 69% 80% 51% 93% 58%
Unknown 82% 59% 47% 28% 71% 66% 74% 41% 86% 54%
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Table 1 shows the significant associations on 
regressing QoL with each of the biopsy 
experience statement. In the multivariate 
analysis, adjustment was made for socio-
demographics and clinical factors, most 
notable of these were cancer diagnosis, health 
anxiety and urinary retention post-biopsy.  
Following adjustment, men who 
agreed/strongly agreed that the biopsy was 
embarrassing, painful, stressful, and worrisome 
had lower QoL in the weeks post-biopsy than 
those who did not experience the biopsy in this 
way.  Men who found the biopsy to be 
reassuring had a higher QoL post-biopsy. 
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